UPDATE: Deutsche Bank Reiterates on Aflac on Multiple Long-Term Catalysts

In a report published Wednesday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on

, and raised the price target from $67.00 to $71.00. In the report, Deutsche Bank noted, “We spent Nov 6 with Aflac's IR. We left with better understanding of several long-term catalysts: (1) Everwell, (2) private broker exchanges, (3) Japan Post, (4) potential for additional reinsurance deals and (4) increased copays in Japan's national healthcare system. Most of these catalysts won't emerge before 2H15. While the stock price doesn't fully reflect these catalysts, we find it difficult to recommend buying AFL 18 months or more in advance. Barring changing circumstances, we shall revisit ahead of 2014's investor day.” Aflac closed on Tuesday at $65.25.